Development of a Virosomal RSV Vaccine Containing 3d-Phad® Adjuvant: Formulation, Composition, and Long-Term Stability
Pharmaceutical Research - United States
doi 10.1007/s11095-018-2453-y
Full Text
Open PDFAbstract
Available in full text
Date
July 3, 2018
Authors
Publisher
Springer Science and Business Media LLC